INTESTINAL MICROBIOTA AND USE OF PROBIOTICS IN PEDIATRIC PRACTICE: NEWS
https://doi.org/10.15690/pf.v12i1.1245
Abstract
Condition of intestinal microbiota is a key factor of a child's health. According to the latest studies, distinctness and certain stability of every person's microbiota is to a large extent determined genetically; at the same time, microbiocenosis is sensitive to external exposure, i.e. it is labile. The article presents new data on the intestinal microflora's composition and function, as well as on the nature of interaction in the microbiocenosis-host system. Intestinal microflora directly affects formation of a child's immune system, ensures protection from pathogens and takes part in all types of metabolism. The article presents modern approaches to intestinal microflora modulation and use of probiotics to prevent and treat various pathologies in pediatric practice.
About the Authors
S. G. Makarova
Scientific Center of Children's Health, Moscow, Russian Federation
Sechenov First Moscow Medical State University, Moscow, Russian Federation
Russian Federation
Russian Federation
L. S. Namazova-Baranova
Scientific Center of Children's Health, Moscow, Russian Federation
Sechenov First Moscow Medical State University, Moscow, Russian Federation
Pirogov Russian National Medical Research University, Moscow, Russian Federation
Russian Federation
Russian Federation
References
1. Methe B.A., Nelson K.E., Pop M., Creasy H.H., Giglio M.G., Huttenhower C., Gevers D., Petro- sino J., Abubucker S., Badger J.H., Chinwalla A.T., Ear A.M., FitzGerald M.G., Fulton R.S., Hallsworth-Pepin K., Lobos E.A., Madupu R., Magrini V., Martin J.C., Mitreva M., Muzny D.M., Sodergren E.J., Versalovic J. A framework for human microbiome research. Nature. 2012; 486: 215–221.
2. Huttenhower C., Gevers D., Knight R., Abu-bucker S., Badger J.H., Chinwalla A.T., Creasy H.H., Earl A.M., FitzGerald M.G., Fulton R.S., Giglio M.G., Hallsworth-Pepin K., Lobos E.A., Madupu R., Magrini V., Martin J.C., Mitreva M., Muzny D., Sodergren E., Versalovic J., Wollam A.M., Worley K.C., Wortman J.R., Young S.K., Zeng Q., Aagaard K. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486: 207–214.
3. Kau A.L., Ahern P.P., Griffin N.W., Goodman A.L., Gordon J.I. Human nutrition, the gut microbiome and the immune system. Nature. 2011; 474 (7351): 327–36.
4. Goodacre R. Metabolomics of a superorganism. J Nutr. 2007; 137 (Suppl. 1): 259S–266S.
5. Claesson M.J., Jeffery I.B., Conde S., Power S.E., O’Connor E.M., Cusack S., Harris H.M., Coakley M., O'Sullivan O., Fitzgerald G.F., Deane J., O'Connor M., Harnedy N., O'Connor K., O'Mahony D., van Sinderen D., Wallace M., Brennan L., Stanton C., Marchesi J.R., Fitzgerald A.P., Shanahan F., Hill C., Ross R.P., O'Toole P.W. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012; 488 (7410): 178−84.
6. Arumugam M., Raes J., Pelletier E., Paslier D.L., Yamada T., Mende D.R. et al. Enterotypes of the human gut microbiome. Nature. 2011; 73: 174−180.
7. O’Toole’s P.W. Categorization of the gut microbiota: enterotypes or gradients? Nature Rev Microbiol. 2012; 10: 591−592.
8. Loranskaya I.D., Boldyreva M.N., Trofimov D.Yu., Lavrent'eva O.A. Abdominal and parietal microbiota of the colon along with irritable bowel syndrome. Farmateka = Pharmateca. 2013; 18: 61−66.
9. Feng T., Elson C.O. Adaptive immunity in the host-microbiota dialog. Mucosal Immunol. 2011; 4: 15–21.
10. Camilleri M. Serotonin in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2009;16: 53–9.
11. Cammarota G., Ianiro G., Cianci R., Bibbò S., Gasbarrini A., Currò D. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy. Pharmacol Ther. 2015 Jan 3. pii: S0163−7258(14)00235-6.
12. Proal A.D., Albert P.J., Marshall T.G. Autoimmune disease in the era of the metagenome. Autoimmunity Reviews. 2009 Jul; 8 (8): 677−81.
13. Devaraj S., Hemarajata P., Versalovic J. The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem. 2013 Apr; 59 (4): 617−28.
14. West C.E., Renz H., Jenmalm M.C., Kozyrskyj A.L., Allen K.J., Vuillermin P., Prescott S.L; in-FLAME Microbiome Interest Group; in-FLAME Microbiome Interest Group. The gut microbiota and inflammatory noncommunicable diseases: Associations and potentials for gut microbiota therapies. J Allergy Clin Immunol. 2015 Jan; 135 (1): 3−13.
15. Sanchez M., Panahi S., Tremblay A. Childhood Obesity: A Role for Gut Microbiota? Int J Environ Res Public Health. 2014 Dec 23; 12 (1): 162−175.
16. Clarke G., Stilling R.M., Kennedy P.J., Stanton C., Cryan J.F., Dinan T.G. Minireview: Gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014 Aug; 28 (8): 1221−38.
17. Yatsunenko T., Rey F.E., Manary M.J., Trehan I., Dominguez-Bello M.G., Contreras M., Magris M., Hidalgo G., Baldassano R.N., Anokhin A.P., Heath A.C., Warner B., Reeder J., Kuczynski J., Caporaso J.G., Lozupone C.A., Lauber C., Clemente J.C., Knights D., Knight R., Gordon J.I. Human gut microbiome viewed across age and geography. Nature. 2012; 486: 222–227.
18. Koenig J.E., Spor A., Scalfone N., Fricker A.D., Stombaugh J., Knight R., Angenent L.T., Ley R.E. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA. 2011 Mar 15; 108 (Suppl. 1): 4578−85.
19. Chilton S.N., Burton J.P., Reid G. Inclusion of Fermented Foods in Food Guides around the World. Nutrients. 2015; 7 (1): 390−404.
20. Ozen M., Dinleyici E.C. The history of probiotics: the untold story. Benef Microbes. 2015; 9: 1−7.
21. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. FAO/WHO. 2011. URL: www.fao.org
22. Roberfroid M.B. Concepts in functional foods: the case of inulin and oligofructose. J Nutr. 2007; 137: 2709−2716.
23. Makarova S.G. Prebiotics as a functional component of child nutrition. Voprosy sovremennoi pediatrii = Current pediatrics. 2013; 12 (5): 8–17.
24. Gorbach S.L. Probiotics in the third millennium. Digest Liver Dis. 2002; 34 (Suppl. 21): S2−7.
25. McFarland L.V. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006; 101: 812−822.
26. Kornienko E.A. Modern principles of selection of probiotics. Detskie infektsii = Child infections. 2007; 3: 64−69.
27. Kailasapathy K., Chin J. Survival and therapeutic potential ofprobiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol. 2000; 78 (Suppl. 1): 80−88.
28. Favier С.F., De Vos W.M., Akkermans A.D. Development of bacterial and bifidobacterial communities infeces ofnewborn babies. Anaerobe. 2003; 9: 219−229.
29. Butel M.J., Suau A., Campeotto F., Magne F., Aires J., Ferraris L., Kalach N., Leroux B., Dupont C. Conditions of bifidobacterial colonization in preterm infants: a prospective analysis. J Ped Gastroenterol Nutr. 2007; 44 (5): 577−582.
30. Rijkers G.T., Bengmark S., Enck P., Haller D., Herz U., Kalliomaki M., Kudo S., Lenoir-Wijnkoop I., Mercenier A., Myllyluoma E., Rabot S., Rafter J., Szajewska H., Watzl B., Wells J., Wolvers D., Antoine J.M. Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr. 2010; 140 (3): 671−6.
31. Patten D.A., Laws A.P. Lactobacillus-produced exopolysaccharides and their potential health benefits: a review. Benef Microbes. 2015; 7: 1−15.
32. Yan F., Polk D.B. Probiotics and immune health. Curr Opin Gastroenterol. 2011; 27: 496−501.
33. Versalovic J. The Human Microbiome and Probiotics: Implications for Pediatrics. Ann Nutr Metab. 2013; 63 (Suppl. 2): 42–52.
34. Moayyedi P., Ford A.C., Talley N.J., Foxx-Orenstein A.E., Brandt L.J., Quigley E.M. The efficacy of probi-otics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010; 59: 325−332.
35. Issa I., Moucari R. Probiotics for antibiotic-associated diarrhea: Do we have a verdict? World J Gastroenterol. 2014 Dec 21; 20 (47): 17788−17795.
36. Millar M., Wilks M., Costeloe K. Probiotics for preterm infants? Arch Dis Child Fetal Neonatal. 2003; 88 (5): F354−8.
37. Goldenberg J.Z., Ma S.S., Saxton J.D., Martzen M.R., Vandvik P.O., Thorlund K., Guyatt G.H., Johnston B.C. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013; 5: CD006095.
38. Piescik-Lech M., Shamir R., Guarino A., Szajewska H. Review article: the management of acute gastroenteritis in children. Aliment Pharmacol Ther. 2013; 37: 289–303.
39. Thomas D.W., Greer F.R. Probiotics and prebiotics in pediatrics. Pediatrics. 2010; 126: 1217–1231.
40. Kalliomäki M., Kirjavainen P., Eerola E., Kero P., Salminen S., Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol. 2001 Jan; 107 (1): 129−34.
41. Björkstén B., Sepp E., Julge K., Voor T., Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol. 2001 Oct; 108 (4): 516−20.
42. Songjinda P., Nakayama J., Tateyama A., Tanaka S., Tsubouchi M., Kiyohara C., Shirakawa T., Sonomoto K. Differences in developing intestinal microbiota between allergic and non-allergic infants: a pilot study in Japan. Biosci Biotechnol Biochem. 2007 Sep; 71 (9): 2338−42.
43. Kalliomäki M., Salminen S., Poussa T., Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007 Apr; 119 (4): 1019−21.
44. Savilahti E. Probiotics in the Treatment and Prevention of Allergies in Children. Biosci Microflora. 2011; 30 (4): 119–128.
45. Azad Meghan B., Coneys J.G., Kozyrskyj A.L., Field C.J., Ramsey C.D., Becker A.B., Friesen Carol, Abou-Setta A.M. Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis. BMJ. 2013; 347: f6471.
46. Food Allergy and Anaphylaxis Guidelines. EAACI. 2014. 278 p.
47. Tang R.B., Chang J.K., Chen H.L. Can probiotics be used to treat allergic diseases? J Chin Med Assoc. 2015 Jan 6. Р. S1726−4901.
48. Fiocchi A., Burks W., Bahna S.L., Bielory L., Boyle R.J., Cocco R., Dreborg S., Goodman R., Kuitunen M., Haahtela T., Heine R.G., Lack G., Osborn D.A., Sampson H., Tannock G.W., Lee B.W. Clinical use of probiotics in pediatric allergy (CUPPA): a World Allergy Organization position paper. World Allergy Organ J. 2012; 5: 148–167.
49. Isolauri E. Dietary modification of atopic disease: of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD) / American Academy of Dermatology Association «Administrative Regulations for Evidence-Based Clinical Practice Guidelines». J Am Acad Dermatol. 2004; 50 (3): 391−404.
50. Boyle R.J., Bath-Hextall F.J., Leonardi-Bee J., Murrell D.F., Tang M.L. Probiotics for treating eczema. Cochrane Database Syst Rev. 2008 Oct 8; 4: CD006135.
51. Guandalini S., Magazzu G., Chiaro A., La Balestra V., Di Nardo G., Gopalan S., Sibal A., Ro- mano C., Canani R.B., Lionetti P., Setty M. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, ran- domized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr. 2010; 51: 24–30.
52. Bausserman M., Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr. 2005; 147: 197–201.
53. Mayer E.A. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011; 12: 453–466.
54. Morgan X.C., Tickle T.L., Sokol H., Gevers D., Devaney K.L., Ward D.V., Reyes J.A., Shah S.A., LeLeiko N., Snapper S.B., Bousvaros A., Korzenik J., Sands B.E., Xavier R.J., Huttenhower C. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012; 13: 76−79.
55. Fernandez-Feo M., Wei G., Blumenkranz G., Dewhirst F.E., Schuppan D., Oppenheim F.G., Helmerhorst E.J. The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity. Clin Microbiol Infect. 2013; 19: E386–E394.
56. Franz M.J., VanWormer J.J., Crain A.L., Boucher J.L., Histon T., Caplan W., Bowman J.D., Pronk N.P. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc. 2007; 107: 1755–67.
57. Westrate J.A., van Poppel G., Verschuren P.M. Functional foods, trends and future. Br J Nutr. 2002; 88: S233–5.
58. Han J.L., Lin H.L. Intestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspective. World J Gastroenterol. 2014 Dec 21; 20 (47): 17737−17745.
Review
For citations:
Makarova S.G., Namazova-Baranova L.S. INTESTINAL MICROBIOTA AND USE OF PROBIOTICS IN PEDIATRIC PRACTICE: NEWS. Pediatric pharmacology. 2015;12(1):38-45. (In Russ.) https://doi.org/10.15690/pf.v12i1.1245
Views:
4828
Email this article 